Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy

BACKGROUND AND AIMS: Clinical trials of therapy against chronic hepatitis C virus (HCV) infection including boceprevir (BOC) or telaprevir (TVR) plus pegylated interferon and ribavirin (PR) have reported considerably higher response rates than those achieved with PR alone. This study sought to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Neukam, Karin, Munteanu, Daniela I., Rivero-Juárez, Antonio, Lutz, Thomas, Fehr, Jan, Mandorfer, Mattias, Bhagani, Sanjay, López-Cortés, Luis F., Haberl, Annette, Stoeckle, Marcel, Márquez, Manuel, Scholten, Stefan, de los Santos-Gil, Ignacio, Mauss, Stefan, Rivero, Antonio, Collado, Antonio, Delgado, Marcial, Rockstroh, Juergen K., Pineda, Juan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414348/
https://www.ncbi.nlm.nih.gov/pubmed/25923540
http://dx.doi.org/10.1371/journal.pone.0125080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414348/
https://www.ncbi.nlm.nih.gov/pubmed/25923540
http://dx.doi.org/10.1371/journal.pone.0125080

Ejemplares similares